✦ LIBER ✦

Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease

✍ Scribed by Y. Horai; T. Miyamura; K. Shimada; S. Takahama; R. Minami; M. Yamamoto; E. Suematsu

Book ID: 108849431
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 645 KB
Volume: 37
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2010.01234.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of interstitial lung disease associ

Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis

✍ Ji Hyeon Ju; Sung-Il Kim; Jun-Hee Lee; Sang-Il Lee; Wan-Hee Yoo; Jung-Yoon Choe; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Interstitial Lung Disease in Patients wi

Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced

✍ Hallowell, Robert W.; Horton, Maureen R. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 265 KB

HIGH RESOLUTION COMPUTED TOMOGRAPHY OF T

HIGH RESOLUTION COMPUTED TOMOGRAPHY OF THE LUNGS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE

✍ McDONAGH, J.; GREAVES, M.; WRIGHT, A. R.; HEYCOCK, C.; OWEN, J. P.; KELLY, C. 📂 Article 📅 1994 🏛 Oxford University Press 🌐 English ⚖ 505 KB

Leflunomide-induced interstitial lung di

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis

✍ Sawada, T.; Inokuma, S.; Sato, T.; Otsuka, T.; Saeki, Y.; Takeuchi, T.; Matsuda, 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 93 KB

Leflunomide use and the risk of intersti

Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis

✍ Samy Suissa; Marie Hudson; Pierre Ernst 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud

A fatal case of acute exacerbation of in

A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab

✍ Shin-ya Kawashiri, Atsushi Kawakami, Noriho Sakamoto… 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 345 KB